Search

Search Language

italiano / Italian | Use language selector above (below, on mobile) to search additional languages

Open filter

92 items matching filters

Search Results

Insight

EDGAR Next: What Filers Should Know

by Niki Fang, Albert Vanderlaan and Bobby Bee
18 minute read | April.17.2025

Orrick's Capital Markets team addresses common questions for public companies regarding the SEC's new "EDGAR Next" rules.

Insight

First Lawsuit Filed Under Washington’s My Health My Data Act

by Thora Johnson, Sundeep Kapur, Emily S. Tabatabai, Aravind Swaminathan and Peter Graham
4 minute read | February.24.2025

On February 10, 2025, a Washington state resident filed a lawsuit against Amazon under the Washington My Health My Data Act.

Insight

Telehealth Transformation: Innovating Mental Health Care
Life Sciences Snapshot – Q1 2025

11 minute read | February.19.2025

Life Sciences Snapshot – Q1 2025 – A Quarterly Report on Financing Trends

U.S. life sciences VC rebounded in 2024 with rising deal and exit value. Orrick’s Life Sciences Snapshot breaks down the key trends.

Insight

Massachusetts Adopts Law to Regulate Domestic Money Transmission

2 minutes | January.10.2025

The new law is generally consistent with the Money Transmission Modernization Act (MTMA) and takes effect in September 2025.

Insight

FDA Issues Draft Guidance on AI-Enabled Medical Devices

by Georgia C. Ravitz, Shari Esfahani, Stephen Thau, Thora Johnson, Jeremy D. Sherer and Amy M. Joseph
3 minute read | January.07.2025

The FDA has shared draft guidance on the design and development of AI-enabled medical devices and marketing submissions for those devices.

Insight

DEA Issues Third Extension of Telemedicine Prescribing Flexibilities

by Amy M. Joseph, Jeremy D. Sherer, Melania Jankowski and Anna Booth
2 minute read | January.02.2025

The Third Extension allows providers to continue prescribing controlled substances without a prior in-person examination through December 31, 2025.

Insight

Life Sciences Snapshot – Q4 2024 – A Quarterly Report on Financing Trends

14 minute read | December.20.2024

Healthtech Horizons: Navigating Regulation, Investment, and Strategy in a Transforming Market

Insight

Fifth Circuit Strikes Down Nasdaq Board Diversity Rules

by Albert Vanderlaan, Soo Hwang and Bobby Bee
3 minute read | December.18.2024

The U.S. Court of Appeals for the Fifth Circuit vacated the SEC’s approval of Nasdaq’s board diversity rules.

Insight

SEC Comment Letter Trend: AI-Related Disclosures

by Marsha Mogilevich, Albert Vanderlaan and Bobby Bee
10 minute read | December.12.2024

Orrick's summary of SEC disclosure comments surrounding the use of AI and key issues raised through its guidance & enforcement actions as of October ...

Insight

California Gov. Newsom Vetoes Controversial Frontier AI Bill as Non-Responsive to “Actual Risks”

by Jeremy Kudon, Shannon Yavorsky and Matthew E.S. Coleman
4 minute read | September.30.2024

California Gov. Gavin Newsom has vetoed SB 1047 – the controversial AI regulation bill that both chambers of the California legislature passed by ...

Insight

Navigating University Technology Licensing for Startups: Key Considerations

by Stephen Thau and David Sharrow
4 minute read | September.23.2024

Licensing university technology to start a company is complex. Founders should be aware of key challenges and opportunities in the process.

Insight

The EU AI Act: What Life Sciences and Digital Health Companies Should Know

by Julia Apostle, Daniel Kadin and David Sharrow
4 minute read | September.13.2024

The EU AI Act Series: What Life Sciences and Digital Health Companies Should Know

EU AI Act is a landmark piece of legislation that establishes the first comprehensive framework for regulating the use of artificial intelligence.